RT Journal Article
SR Electronic
T1 Adaptive cyclic exit strategies from lockdown to suppress COVID-19 and allow economic activity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.04.20053579
DO 10.1101/2020.04.04.20053579
A1 Karin, Omer
A1 Bar-On, Yinon M.
A1 Milo, Tomer
A1 Katzir, Itay
A1 Mayo, Avi
A1 Korem, Yael
A1 Dudovich, Boaz
A1 Yashiv, Eran
A1 Zehavi, Amos J.
A1 Davidovitch, Nadav
A1 Milo, Ron
A1 Alon, Uri
YR 2020
UL http://medrxiv.org/content/early/2020/04/26/2020.04.04.20053579.abstract
AB Many countries have applied lockdown that helped suppress COVID-19, but with devastating economic consequences. Here we propose exit strategies from lockdown that provide sustainable, albeit reduced, economic activity. We use mathematical models to show that a cyclic schedule of 4-day work and 10-day lockdown, or similar variants, can, in certain conditions, suppress the epidemic while providing part-time employment. The cycle reduces the reproduction number R by a combination of reduced exposure time and an anti-phasing effect in which those infected during work days reach peak infectiousness during lockdown days. The number of work days can be adapted in response to observations. Throughout, full epidemiological measures need to continue including hygiene, physical distancing, compartmentalization and extensive testing and contact tracing. We do not call for immediate adoption of this policy, but rather to consider it as a conceptual framework, which, when combined with other interventions to control the epidemic, can offer the beginnings of predictability to many economic sectors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data supplied in the submitted file